Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01603420 · ClinicalTrials.gov registry record · Phase 2
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
A Phase 2 study, sponsored by Proton Collaborative Group.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT01603420: Clinical Trial Phase 2 study, sponsored by Proton Collaborative Group.
NCT01603420 is a Phase 2 study that was terminated before completion, run by Proton Collaborative Group. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01603420, a Phase 2 study, was terminated before completion, sponsored by Proton Collaborative Group.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects on prostate cancer using radiation therapy with or without chemotherapy.
Primary Outcome
Measurement of Freedom from Failure i.e. the first occurence of clinical failure (local recurrence, regional recurrence, or distant metastasis), biochemical failure by the Phoenix definition (Prostate Specific Antigen \[PSA\] \> = 2 ng/ml over the nadir PSA discounting bounces per the investigators discretion), or the start of salvage therapy including androgen deprivation. This study was terminated prior to the time frame of 2 years being reached. Therefore, this outcome was assessed at time o
Interventions
- DRUG Docetaxel
- DRUG Luteinizing hormone-releasing hormone (LHRH)
- OTHER Conformal Radiation Therapy (RT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-05 |
| Phase | Phase 2 |
Why NCT01603420 stopped before completion
NCT01603420 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Docetaxel is the first listed.
NCT01603420 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01603420 about?
NCT01603420 is a clinical study titled "External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer". The purpose of this study is to compare the effects on prostate cancer using radiation therapy with or without chemotherapy.
What is the current status of trial NCT01603420?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2012-07. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01603420?
The interventions under investigation include: Docetaxel (DRUG), Luteinizing hormone-releasing hormone (LHRH) (DRUG), Conformal Radiation Therapy (RT) (OTHER).
Who is sponsoring clinical trial NCT01603420?
This trial is sponsored by Proton Collaborative Group, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01603420's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia